Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.

Authors:
Anna Czarnota Anna Offersgaard Anne Finne Pihl Jannick Prentoe Jens Bukh Judith Margarete Gottwein Krystyna Bieńkowska-Szewczyk Katarzyna Grzyb

Vaccines (Basel) 2020 Jun 10;8(2). Epub 2020 Jun 10.

Laboratory of Virus Molecular Biology, Intercollegiate Faculty of Biotechnology, University of Gdańsk, 80-309 Gdańsk, Poland.

Hepatitis C virus (HCV) infection with associated chronic liver diseases is a major health problem worldwide. Here, we designed hepatitis B virus (HBV) small surface antigen (sHBsAg) virus-like particles (VLPs) presenting different epitopes derived from the HCV E2 glycoprotein (residues 412-425, 434-446, 502-520, and 523-535 of isolate H77C). Epitopes were selected based on their amino acid sequence conservation and were previously reported as targets of HCV neutralizing antibodies. Chimeric VLPs obtained in the expression system, in combination with the adjuvant Addavax, were used to immunize mice. Although all VLPs induced strong humoral responses, only antibodies directed against HCV 412-425 and 523-535 epitopes were able to react with the native E1E2 glycoprotein complexes of different HCV genotypes in ELISA. Neutralization assays against genotype 1-6 cell culture infectious HCV (HCVcc), revealed that only VLPs carrying the 412-425 epitope induced efficient HCV cross-neutralizing antibodies, but with isolate specific variations in efficacy that could not necessarily be explained by differences in epitope sequences. In contrast, antibodies targeting 434-446, 502-520, and 523-535 epitopes were not neutralizing HCVcc, highlighting the importance of conformational antibodies for efficient virus neutralization. Thus, 412-425 remains the most promising linear E2 epitope for further bivalent, rationally designed vaccine research.

Download full-text PDF

Source
http://dx.doi.org/10.3390/vaccines8020294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350033PMC
June 2020

Publication Analysis

Top Keywords

hepatitis virus
12
virus-like particles
8
502-520 523-535
8
523-535 epitopes
8
434-446 502-520
8
hcv
7
epitopes
5
antibodies
5
hcv neutralizing
4
neutralizing antibodies
4
vlps carrying
4
epitope induced
4
targets hcv
4
revealed vlps
4
reported targets
4
carrying 412-425
4
antibodies chimeric
4
conservation reported
4
sequence conservation
4
412-425 epitope
4

Keyword Occurance

Similar Publications

The recent outbreak of acute and severe hepatitis of unknown etiology in children: a possible role of human adenovirus infection?

Authors:
Mohamad S Hakim

J Med Virol 2022 May 16. Epub 2022 May 16.

Department of Microbiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

The Public Health Scotland (PHS) was notified at the end of March 2022 that five children aged 3-5 years had presented to the Royal Hospital for Children in Glasgow with acute hepatitis of unknown etiology within a three-week period.Keywords This article is protected by copyright. All rights reserved. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Patient Navigation Increases Linkage to Care and Receipt of Direct-Acting Antiviral Therapy in Patients with Hepatitis C.

Authors:
Joslyn Strebe Nicole E Rich Li Wang Amit G Singal Jennifer McBryde Mauro Silva Victoria Jackson Hannah Fullington Deyaun L Villarreal Stephanie Reyes Bertha Flores Mamta K Jain

Clin Gastroenterol Hepatol 2022 May 13. Epub 2022 May 13.

Parkland Health and Hospital System Dallas, Texas; Department of Internal Medicine, Division of Infectious Disease and Geographic Medicine, UT Southwestern Medical Center, Dallas, Texas. Electronic address:

Background: Patient navigation interventions can improve health outcomes in underserved, low-income and racial and ethnic minority groups, who often experience health disparities. We examined the effectiveness of patient navigation to improve linkage to hepatitis C virus (HCV) treatment receipt in a socioeconomically disadvantaged, racially diverse patient population.

Methods: We performed a pre-post analysis evaluating the effectiveness of a patient navigation program among baby boomers who tested positive for HCV in a safety-net health system. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.

Authors:
Catharina J Alberts Gary M Clifford Damien Georges Francesco Negro Olufunmilayo A Lesi Yvan J-F Hutin Catherine de Martel

Lancet Gastroenterol Hepatol 2022 May 13. Epub 2022 May 13.

Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Background: Empirical, updated country-level estimates on the proportion of cirrhosis attributable to viral hepatitis are required. We estimated the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with cirrhosis at country, regional, and global levels as an approximation for the fractions of cirrhosis attributable to viral hepatitis.

Methods: In this systematic review, we searched MEDLINE, Embase, Web of Science, and Scielo between Jan 1, 1993, and Aug 1, 2021. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Rational fabrication of a DNA walking nanomachine on graphene oxide surface for fluorescent bioassay.

Authors:
Ling Liang Yong Jian Jiang Long Chuan Zhang Hui Liu Yuan Fang Li Chun Mei Li Cheng Zhi Huang

Biosens Bioelectron 2022 May 10;211:114349. Epub 2022 May 10.

Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, PR China. Electronic address:

DNA nanomachines, a delicate type of molecular machines, have been a research hotspot in biotechnology and materials. Here a two-dimensional (2D) DNA walking nanomachine with high working efficiency and low cost was easily assembled by using graphene oxide (GO) as the working platform for precisely fluorescent bioassay through the binding of target hepatitis B virus DNA (HBV-DNA) and the driving force of Exonuclease III (Exo III). The presence of HBV-DNA made continuous Exo III digestion of the FAM-modified DNA (FAM-DNA) in double-strand DNA (dsDNA) part in a burnt-bridge mechanism to output a "one-to-more" amplified signal. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Postpartum Follow-up Care for Pregnant Persons With Opioid Use Disorder and Hepatitis C Virus Infection.

Authors:
Marian Jarlenski Qingwen Chen Katherine A Ahrens Lindsay Allen Anna E Austin Catherine Chappell Julie M Donohue Lindsay Hammerslag Paul Lanier Mary Joan McDuffie Jeffrey Talbert Lu Tang Elizabeth E Krans

Obstet Gynecol 2022 May 5;139(5):916-918. Epub 2022 Apr 5.

Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania; the Muskie School of Public Service, University of Southern Maine, Portland, Maine; the Department of Health Policy, Management, and Leadership, West Virginia University School of Public Health, Morgantown, West Virginia; the Department of Maternal and Child Health, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina; the Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; the Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky; the School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; the Center for Community Research and Service, University of Delaware, Newark, Delaware; and the Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap